SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Zirdu who wrote (4701)7/2/1998 12:59:00 PM
From: Steve Fancy  Read Replies (1) | Respond to of 6136
 
That maybe, but her comments *never* move the stock, and her 12 month price target has been the same since mid '96. Maybe her credibility problem is just with AGPH. When Doug Lind speaks, I expect the stock to respond accordingly. Seems the more Elise talks, the stock goes down.

sf



To: Zirdu who wrote (4701)7/2/1998 1:01:00 PM
From: Vector1  Respond to of 6136
 
I have read Elise's note and it is well reasoned. I think her 2000 estimate of $3.65 a share is out of line. But with a little luck and a follow on product approval $3.00 in 2001 is doable.
v1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News